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Abstract 
The purpose of this paper is to investigate the relation between oxidative stress and advanced glycation end 
products in patients suffering from different stages primary open angle glaucoma (POAG) and complications of 
glaucoma progression. Forty five patients suffering from POAG classified into three stages; mild, moderate and 
advanced as well as fifteen healthy "non- diabetic subjects" (age and sex matched healthy controls) were 
selected from the outpatient clinic in the Research Institute of Ophthalmology (RIO) Giza Egypt.nitric oxide 
(NO), malondialdehyde (MDA), ascorbic acid (vitamin C), α-tocopherol (vitamin E), catalase activity (CAT), 
reduced glutathione (GSH), superoxide dismutase (SOD) and advanced glycation end products (AGEs) were 
estimated in all studied groups. A significant increase in MDA, NO and AGEs levels was detected in mild, 
moderate and advanced glaucoma compared to control, also significant decreases in vitamin C, vitamin E, GSH, 
and SOD activities were found in mild, moderate and advanced glaucoma compared to control. No significant 
change was found in catalase activity in all groups compared to control. Statistical significant positive 
correlations were found between intra ocular pressure (IOP) and disease severity. this study clearly 
demonstrated increased accumulation of AGEs, lipid peroxidation products along with impairment of the 
antioxidant status in patients with primary open angle glaucoma.  
------------------------------------------------------------------------ 
* Corresponding author.  
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We suggest that AGEs measurement could be used as a diagnostic marker in primary screening programs for 
diagnosis and prediction of the development and progression of glaucoma. 
Key words: (Primary open angle glaucoma; advanced glycation end products; intraocular pressure; visual field; 
glaucoma progression; oxidative stress; antioxidants). 
1. Introduction   
Glaucoma is the second most common cause blindness after cataracts in the world. Primary open-angle 
glaucoma accounts for around 70% of the total glaucoma cases worldwide. Glaucoma is a term describing a 
group of ocular disorders with multi-factorial etiology united by a clinically characteristic intraocular pressure-
associated optic neuropathy [1]. 
Actis and his colleagues in [2] confirm that intraocular pressure (IOP) remains the main risk factor for glaucoma 
progression; age and family history are great risk factors as underlined in the last decades; female sex can be an 
important risk factors. 
 If the condition is detected early enough, it is possible to arrest the development or slow the progression with 
medical and surgical means. Blindness occurs as a gradual loss of visual field resulting from the death of retinal 
ganglion cells. The underlying mechanism for open-angle glaucoma involves degeneration of the trabecular 
meshwork, usually by unknown causes, that lead to aqueous backup and chronically elevated eye pressure. With 
prolonged high pressure, the ganglion nerves in the retina atrophy [3]. 
An imbalance between pro-oxidants and antioxidants, in favor of the former, results in oxidative stress. This 
insult, in turn, may lead to damage of a variety of macromolecules, such as proteins, lipids, sugar residues, or 
DNA, and thereby leads, in extreme cases, to growth arrest, growth modulation, or cell death, such as death of 
retinal ganglion cells in glaucoma. Oxidative stress has been proposed to play a role in the pathogenesis of 
glaucomatous optic neuropathy [4].   
Advanced glycation end products is receiving considerable attention as a possible modulator in visual disorders 
including glaucoma. The present study aims to investigate the association between AGEs in POAG based on the 
disease severity (mild, moderate and advanced) and its progression. 
2. Subjects and Methods 
The study was performed on forty five patients suffering from POAG of both sexes. The study was performed 
between 2015 and 2017; all cases were selected among those attending the outpatient clinics of Research 
Institute of Ophthalmology, Giza, Egypt. A group fifteen of age and sex matched healthy subjects with no 
history of ophthalmologic diseases or any other health complications, served as controls. Their mean age was 
25.13±1.67 years, five males and ten females. Ethical Committee approval of the Research Institute of 
Ophthalmology, Giza, Egypt was obtained. 
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Patients in this study were classified into three main groups according to visual field; Group one: mild group: 
MD<(-)6.00 dB include fifteen patients with a mean age 55.73±3.15 years, five males and ten females. Group 
two: moderate group: MD   > (-) 6.00 dB < (-)12 dB, include fifteen patients with a mean age 60.13 ±1.94, seven 
males and eight females. Group three: advanced group: MD   > (-) 12.00 dB, include fifteen patients with a mean 
age 64.27±2.29, six males and nine females.   
2.1. Ophthalmological examinations 
Ophthalmic examination was done for patients and controls. Visual acuity, slit lamp biomicroscopy using 90 D 
lens, gonioscopy using Goldmann three mirror contact lens, intraocular pressure measurement using Goldmann 
applanation tonometer and visual field by the Humphrey automated visual field analyzer 24-2 program were 
performed. A detailed medical history was taken for each patient. Strict criteria were used to recruit patients for 
this study. Patients with acute and chronic infections, malignancy, liver diseases, acute and chronic nephritis and 
cirrhosis were excluded from the study. 
2.2. Biochemical analyses 
Blood samples were withdrawn from each subject. Whole blood, serum and plasma were prepared. Whole blood 
was used to determine reduced glutathione (GSH) according to the method described by Beutler and his 
colleagues in [5]. The activity of superoxide dismutase (SOD) was determined according to the method 
described by the authors in [6]. Plasma catalase activity was determined using the kit obtained from Bio-
diagnostic, (Egypt) according to the method described by Aebi in [7]. 
Serum was used to determine malondialdehyde (MDA) according to the method described in [8]. Quantitative 
determination of nitrite oxide in serum was carried out by a spectrophotometric method according to Moshage 
and his colleagues in [9]. Colorimetric technique was performed for estimation of vitamin "C" using folin 
phenol reagent as described by the authors in [10]. An improved micro procedure for the determination of 
tocopherol in serum is reported in [11]. 
The advanced glycation end products (AGEs) were determined by the enzyme linked immunosorbent assay 
(ELISA) procedure using a kit supplied by Cell Biolabs, Inc, CA 92126, San Diego, (USA). 
2.3. Collection of aqueous humor samples 
Collection of aqueous humor was performed during cataract or glaucoma surgery. Aqueous humor 0.1-0.2 ml 
was aspirated at the beginning of surgery through a paracentesis using a 27 gauge needle on a tuberculin micro 
syringe. Blood contamination or iris touch was avoided. All aqueous humor samples were immediately stored at 
-70˚C till assays. 
2.4. Statistical Analysis 
Data were presented as mean ± standard error (SE). All values were statistically analyzed using Microsoft excel 
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(Version 10) and statistical package for social sciences (SPSS) software (Version 10). One-way analysis of 
variance (ANOVA; with post-hoc LSD analysis) was used to compare the groups on continuous variables. The 
degree of association between the variables was assessed using Pearson’s correlation coefficient (r). For all 
statistical tests, P <0.05 was considered as the level of significance. 
3. Results 
Table 1 shows that the mean values±S.E. of age in the control group was 25.13±1.673 years, in the group of 
patients of mild 55.73±3.152, the moderate 60.13±1.944 and in the advanced group 64.26±2.285 years, 
indicating very high statistical significant increase in age in all groups compared to control group. The mean 
values±S.E. of intraocular pressure in control, mild, moderate and advanced groups were 14.40±1.046 mmHg, 
31.53±3.258 mmHg, 37.20±2.736 mmHg and 40.53±3.141 mmHg respectively (figure 1). 
Table 1: The mean ± S.E. and P values of sex (M/F), age (year), and IOP mmHg in the controls, mild, moderate 
and advanced glaucoma groups. 
 
 
Groups with different letters have a statistically significant difference.  
 
Figure1: The mean of IOP in different groups. 
0
10
20
30
40
50
mmHg
IOP 
(mmHg) 
Age 
(year) 
Sex 
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           Parameters 
Groups 
14.40 ±1.046b 25.13 ±1.673b 5/10 Control 
31.53±3.258a 55.73 ± 3.152a 5/10 Mild 
37.20±2.736a 60.13± 1.944a 7/8 Moderate 
40.53±3.141a 64.26 ± 2.285a 6/9 Advanced 
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Table 2: Mean±S.E. and P values of MDA and NO in the control, mild, moderate and advanced glaucoma 
groups. 
 
 
 
 
 
 
 
 
 
Groups with different letters have a statistically significant difference.  
 % Change: Percentage change from normal control. 
As shown in table 2, there was highly statistical significant increase in serum MDA level in the mild group (p-
values<0.01). Also, there was very highly statistical significant increase in serum MDA level in the moderate 
and advanced groups compared to control group (p-values<0.001). 
In addition to statistical significant increase in plasma NO level in the advanced group (p-values<0.05). 
In table 3, there was high statistical significant decrease in serum vitamin C and  E levels, GSH and SOD 
activities in all groups compared to control (p-values<0.001).  
While, there was non-significant decreased in plasma CAT activity in all groups compared to the control group 
(p-values>0.05).  
There was very high statistical significant increase in both blood and aqueous humor AGEs levels (table 4) in all 
groups compared to the control group (p-values<0.001).  
Also there was statistical significant increase in blood and aqueous humor AGEs level in mild and moderate 
groups compared to advanced group (p-values<0.05). 
 
                    Parameters 
Groups 
MDA 
( µmol/L ) 
NO 
( µmol/L ) 
Control mean ±S.E. 1.24± 0.086 b 26.27± 4.614b 
Mild 
(n=15) 
mean ±S.E. 
 *%Change 
1.83 ± 0.148a 
47.6 
36.73 ± 4.709a,b 
39.8 
Moderate 
(n=15) 
mean ±S.E. 
*%Change 
1.92± 0.134a 
54.8 
38.53± 4.563a,b 
46.7 
Advanced 
(n=15) 
mean ±S.E. 
*%Change 
2.01 ± 0.097a 
62.1 
47.67± 5.907a 
81.5 
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Table 3: The mean ± S.E. and P values of vitamin C, vitamin E, CAT, GSH and SOD in the control, mild, 
moderate and advanced glaucoma groups. 
Groups with different letters have a statistically significant difference. 
 % Change: Percentage change from normal control. 
Table 4: The mean±S.E. and P values of aqueous humor and plasma advanced glycation end products levels 
(µg/ml) in the control, mild, moderate and advanced stages groups. 
SOD 
 ( U/ml )  
GSH 
(mg dl) 
CAT   
 (U/L)  
Vitamin E   
(mg/dl ) 
Vitamin C 
(mg/dl )  
               Parameters 
Groups 
118.46± 
24.061a 
17.81± 0.923a 486.92± 
44.207a 
1.09± 
0.075a 
0.62± 0.114a mean± 
S.E. 
Control 
(n=15) 
87.27 ± 
14.528a,b 
-26.3 
13.64 ± 
1.366a,b 
-23.4 
442.08 ± 
20.855a 
-9.2 
0.40 ± 
0.059b 
-63.3 
0.24 ± 0.065b 
-61.3 
mean± 
S.E. 
*%Change 
 
Mild 
(n=15) 
43.46± 2.348b 
-63.3 
12.57± 1.215b 
-29.4 
435.56± 
41.879a 
-10.5 
0.35± 
0.042b 
-67.9 
0.20± 0.026b 
-67.7 
mean± 
S.E. 
*%Change 
 
Moderate 
(n=15) 
35.03 ± 4.657b 
-70.4 
12.35 ± 
1.281b 
-30.7 
381.57± 
25.313a 
-21.6 
0.28 ± 
0.042b 
-74.3 
0.10 ± 0.025b 
-83.9 
mean± 
S.E. 
*%Change 
Advanced 
(n=15) 
Parameters 
Groups  
Aqueous Humor (AGEs)                        
(µg/ml) 
Plasma 
(AGEs)                        
(µg/ml) 
Control mean±S.E. 1.57±0.135c 3.75±0.328c 
Mild 
(n=15) 
mean±S.E. 
*%Change 
2.69±0.194b 
71.33 
 7.23±0.350b 
92.8 
Moderate 
(n=15) 
mean±S.E. 
*%Change 
 2.73±0.161b 
73.9 
7.80± 0.356b 
108 
Advanced 
(n=15) 
mean±S.E. 
*%Change 
3.53±0.216a 
124.8 
12.05±0.415a 
221.3 
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Groups with different letters have a statistically significant difference.  
*% Change: Percentage change from normal control. 
4. Discussion 
Glaucoma is the main cause of irreversible blindness worldwide. Over the last 20 years it has been evident that 
AGEs modification represents a major pathogenic factor in aging and in a spectrum of human diseases such as 
glaucoma and diabetic complication, neuro-degeneration, and atherosclerosis.  
Further evidence suggests that patients with POAG exert mitochondrial abnormalities implicating that 
mitochondrial dysfunction is most probably a consequence of oxidative stress [12].  Oxidative stress has been 
implicated to be a cause of increased intraocular pressure by triggering trabecular meshwork degeneration and 
thus contributing to alterations in the aqueous outflow pathway [13]. This disease is characterized by apoptosis 
of retinal ganglion cells (RGC) and visual field loss that seems to be related to elevated intraocular pressure. 
Several lines of evidences have implicated the crucial role of mitochondrial dysfunction in the pathogenesis of 
glaucoma. Increased mitochondrial oxidative stress in RGC may underlie or contribute to susceptibility of RGC 
to apoptosis [14].   
The current study showed an increase in the level of intra ocular pressure in all groups with the disease 
progression (figure1). A positive correlation between intra ocular pressure in early glaucoma (mild stage) and 
intra ocular pressure in advanced glaucoma (r=0.594, P<0.05) was found. The results of this study reported a 
direct correlation between intra ocular and progression of glaucoma as reported in [14,15].    
Malondialdehyde (MDA) is a biomarker of lipid peroxidation that is widely used, sensitive, and appropriate for 
use in large studies. The data in our study showed highly statistical significant increase in serum MDA level in 
the mild, moderate and advanced glaucoma as compared to controls since the percentage showed an increase; 
47.6%, 54.8%, and 62.1% respectively compared to controls. The authors in [16] reported that destruction of the 
drainage system in POAG is accelerated by lipid peroxidation. These results were in agreement with the 
findings in [17-19]. Our results showed lipid peroxidation much more likely to be involved in the pathogenesis 
of primary open-angle glaucoma and decreased antioxidant defense system and increased oxidative stress might 
play important roles in the pathogenesis of primary open-angle glaucoma. Therefore, these findings suggested 
the possibility that increased oxidative stress which is associated with in primary open-angle glaucoma and 
support the hypothesis that oxidative damage play a role in the in the pathogenesis of glaucoma.  
Nitric oxide (NO) is an important intercellular messenger in the eye. The biochemical function of nitric oxide in 
the eye plays a vital role in the regulation of IOP, local control of ocular blood flow, loss of retinal ganglion 
cells by apoptosis, decrease vascular resistance and in the regulation of ocular vessel tone [20].   
In the current study, there was a significant increase in plasma nitric oxide level in advanced glaucoma 
compared to control. The percentage increased to 39.8%, 46.7%, 81.5% in mild, moderate and advanced 
glaucoma respectively compared to normal control. Our data correlated to authors in [20, 21] who found that the 
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levels of nitric oxide may be increased in glaucoma. These results also agreed with that reported in [18] who 
found serum significantly higher level of nitric oxide in patients with primary open-angle glaucoma than those 
of controls. Our data suggested that, nitric oxide production is associated with increased oxidative stress. It is 
possible that patients with advanced glaucoma may stimulate more an inflammatory reaction to induce a higher 
nitric oxide level than mild or moderate groups.  
The major function of ascorbic acid in the aqueous humor is to protect against oxidative damage, free-radical 
damage and acting as a cofactor for a variety of enzymes. Vitamin C neutralizes oxygen radicals. We found a 
highly statistical significant decrease in serum vitamin C level in mild, moderate and advanced glaucoma as 
compared to control. These findings were in agreement with those reported in [22] who demonstrated a 
significant association between a polymorphism in the ascorbic acid transporter with lower plasma 
concentrations of ascorbic acid in primary open-angle glaucoma. Author in [23] reported that decrease in 
ascorbic acid levels in plasma and aqueous humor can compromise lysosomal degradation in the outflow 
pathway cells with aging and contribute to the pathogenesis of glaucoma. Interestingly, our data reported that, 
the severity of POAG was increased with age. Similarly, our laboratory data of vitamin C level reported 
diminished levels with age increased (table 3). Based on the data obtained here, it is plausible that such 
diminished levels of ascorbic acid with aging may be contributing to the pathogenesis of glaucoma progression. 
We also suggested that vitamin C act as protective action against progression of of glaucoma during the increase 
of oxidative stress. Vitamin C is an important free radical scavenger in the eye and very important to reduce the 
intra ocular pressure in glaucoma patients.   
The results of vitamin E in the present study showed very highly statistical significant drop with percentage 
changes of -63.3%,-67.9% and -74.3% in mild, and moderate and advanced glaucoma respectively as compared 
to control. Moreover, the results showed a significant positive correlation between vitamin E in mild and 
advanced glaucoma, r = 0.572, P<0.05. Also, our data showed significant negative correlation between age and 
vitamin E deficiency in advanced glaucoma (r=-0.566, P<0.05). The data suggested that a relation between age, 
vitamin E deficiency and the glaucoma progress. Another correlation was found between IOP in moderate stage 
and vitamin E level in advanced glaucoma. This means that IOP and the progression of glaucoma were 
increased with the severity of vitamin E deficiency.  
Deficiency of vitamin E in glaucoma patients was reported in [24].  The protective action of vitamin E against 
POAG is believed to be due to the fact that, increase in oxidative stress in glaucoma patients.  
A decrease in the antioxidant capacity may be the consequence of increased oxidative processes [19].    
The current study showed no significant change in the activity of plasma catalase in all stages of the studied 
groups compared to controls. This result coincides with those obtained by Goyal and his colleagues in [24]. In 
spite that the catalase activity showed no significance; there was a gradual decrease in the catalase activity 
according to severity of the glaucoma progression.  The percentage change was recorded -9.2% in the mild and -
10.5% in the moderate, and -21.6% in advanced glaucoma as compared to control. The possible explanation for 
this non-significant decrease in catalase activity associated with glaucoma patients was discussed by authors in 
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[25] who suggested that nitric oxide inhibit the activity of catalase enzyme. 
Our data revealed a negative correlation with non-significant change between the levels of reduced glutathione 
and age in advanced glaucoma (r=-0.221 P>0.05). In the current study, there was a statistical significant decrease 
in erythrocyte reduced glutathione concentration in moderate and advanced glaucoma compared to controls. A 
correlation between the level of reduced glutathione in mild and advanced glaucoma (r=0.712, P<0.01) was 
found. Also, the data of the percentage change showed a decrease in the levels of reduced glutathione; -23.4%, -
29.4%, and -30.7% in mild, moderate and advanced glaucoma respectively compared to control group. Park & 
Moon in [26] found that glaucoma may occur by oxidative damage induced by an abnormal glutathione redox 
state. This result agreed with that reported in [27].   
The laboratory data shows that reduced glutathione concentration observed in our patients in different stages of 
glaucoma and continued deficient reduced glutathione lead to chronic oxidative stress and cause more 
pathogenesis of glaucoma in our patients.  
As shown in the present study data illustrated highly statistical significant decrease in the SOD activity in 
moderate glaucoma as compared to control. Furthermore, there was very highly statistical significant increase in 
SOD activity in advanced group as compared to controls. This was in agreement with that reported in [28]. A 
relation between intraocular pressure in our mild glaucoma and the activity of superoxide dismutase in advanced 
stage was observed (r = - 0.562, P<0.05). The increase in intraocular pressure leading to oxidative damage may 
induce trabecular meshwork degeneration in patients included in this study. On the other side, data of the 
percentage changes were decreased to -26.3%,-63.3% and -70.4% concerning to mild, moderate and advanced 
glaucoma respectively as compared to controls. The decrease in superoxide dismutase activity in patients with 
glaucoma could be due to abnormally high level of oxidative stress affect on the trabecular meshwork and 
causing damage to the cellular component and could directly affect the intra ocular pressure regulation.  
The current data showed higher plasma and aqueous humor advanced glycation end products levels in different 
stages in comparison to control group. The aqueous humor advanced glycation end products levels were 
increased from 2.69±0.194 µg/ml in mild stage to 3.53±o.216 µg/ml in advanced stage. Also, the level of 
advanced glycation end products was increased in plasma from 7.23±0.35 µg/ml in mild stage to 12.05±0.415 
µg/ml in advanced stage. Also results in the current study show a relation between advanced glycation end 
products in plasma and aqueous humor of our patients. A positive correlation found in aqueous humor in mild 
glaucoma and plasma in moderate glaucoma (r=0.600, P<0.05). Similarly, increase in advanced glycation end 
products levels according to the disease severity was found.  
The results in this study showed a positive correlation between intra ocular pressure in both moderate and 
advanced glaucoma and the levels of advanced glycation end products in plasma of the mild stage, but there was 
non-significant change between them (r = 0.042, 0.062, P>0.05 respectively).  
There was a significant positive correlation between advanced glycation end products in aqueous and intraocular 
pressure in advanced stage (r =0.541, p<0.05). Upon these facts, elevation of intraocular pressure with increased 
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levels of advanced glycation end products in advanced group is very important risk factors for the glaucoma 
progression. So the oxidative stress has been implicated to cause increased intraocular pressure by triggering 
trabecular meshwork degeneration and thus contributing to alterations in the aqueous outflow pathway as 
mentioned in [29].   Similarly, as shown in our cases severity of optic nerve damage in advanced glaucoma with 
primary open angle glaucoma is correlated with the elevation of intraocular pressure and changes in the 
trabecular meshwork. High level of intraocular pressure cause recurrent reperfusion which leads to a chronic 
oxidative stress. These results agreed with the reports of Tezel in [30] who suggested that advanced glycation 
end products may contribute to the pathogenesis of optic neuropathy based on the established pivotal role of 
oxidative stress in glaucomatous degeneration and found a connection between advanced glycation end products 
and glaucoma.  
5. Conclusion 
We can concluded that catalase activity, reduced glutathione and superoxide dismutase act as defense enzymes 
to the oxidative stress in glaucoma and the increase in antioxidant activity can be the rule within the initial steps 
of the oxidation process. Plasma and aqueous humor levels of advanced glycation end products have been 
shown to be a biomarker for the severity of glaucoma independent from other well known risk factors such as 
elevation in IOP, MDA and NO. AGEs may be cause degeneration of trabular meshwork and lead to aqueous 
back up. Chronically elevated in the IOP and retinal atrophy may be induced, and also vision may be gradually 
lost. Advanced glycation end products act as predictors of the severity. Finally, oxidative stress is associated 
with the progression of primary open angle glaucoma 
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